Implantable neurostimulator INSPIRE%u2122

for upper airway stimulation

Inspire Therapy is a Treatment Option for Obstructive Sleep Apnea Patients Who Are Unable To Use CPAP A small device inserted in an outpatient procedure Restores muscle tone to open the airway Patient controlled with the Inspire Sleep Remote Cloud-based adherence monitoring Covered by most U.S. insurance companies Many of your patients may be eligible for Inspire. Eligibility considerations: Moderate to severe OSA (AHI 15-65) Unable to get consistent benefit from CPAP Are not significantly overweight Are at least 18 years of age STAR Clinical Trial The Stimulation Therapy for Apnea Reduction (STAR) clinical trial began in 2010 at 22 leading medical centers across the United States and Europe. One-year STAR Trial outcome measures were published in the January 9, 2014 version of the New England Journal of Medicine. Results showed that sleep apnea patients receiving Inspire therapy experienced significant reductions in sleep apnea events and significant improvements in quality of life measures .